View of Baseline serum double-mite (D1+D2) sIgE/tIgE ratio as a predictor of early-phase response to dual-mite subcutaneous immunotherapy in allergic rhinitis

Return to Article Details Baseline serum double-mite (D1+D2) sIgE/tIgE ratio as a predictor of early-phase response to dual-mite subcutaneous immunotherapy in allergic rhinitis Download Download PDF